美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Palvella Therapeutics

25.39

-0.0800-0.31%

盘后：25.390.00000.00%16:05 EDT

成交量：6.60万

成交额：165.65万

市值：2.80亿

市盈率：-3.24

高：26.79

开：25.06

低：24.29

收：25.47

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Palvella Therapeutics

交易所：

NASDAQ

成立时间：

- -

员工人数：

14

公司地址：

125 Strafford Avenue,Suite 360,Wayne,Pennsylvania,United States

官网：

http://www.pieris.com

邮编：

19087

电话：

传真：

- -

简介：

Palvella Therapeutics, Inc.在内华达的法律下成立于2013年5月24日。该公司是一家生物技术公司，历史上发现并开发了基于Anticalin蛋白的药物，以独特和变革性的方式靶向已验证的疾病途径。2024年3月27日，公司实施了措施，以最大限度地提高其从其合作候选药物临床管道收集潜在里程碑的能力，并保持其考虑其他战略选择的能力。该公司的临床管线包括与合作者合作的免疫肿瘤学或IO双特异性药物，包括靶向PD-L1和4-1BB的S095012（也称PRS-344）、靶向CD228和4-1BB的SGN-BB228（也称PRS-346）以及靶向GPC3和4-1BB的BOS-342（也称PRS-342）。Anticalin蛋白是公司专有的，是一类新型疗法，已在临床上通过与领先制药公司的合作关系得到验证。

董事

名称

职位

James Geraghty

Director and Chairman

Stephen S. Yoder

Director,Chief Executive Officer and President

Ann Barbier

Director

Christopher Kiritsy

Director

Jean Pierre Bizzari

Director

Michael Richman

Director

Steven Prelack

Director

股东

名称

职位

Stephen S. Yoder

Director,Chief Executive Officer and President

Allan Reine

Senior Vice President, Chief Financial Officer and Treasurer

Louis A. Matis

Senior Vice President and Chief Development Officer

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PVLA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":25.39,"timestamp":1745611200000,"preClose":25.47,"halted":0,"volume":65991,"hourTrading":{"tag":"盘后","latestPrice":25.39,"preClose":25.39,"latestTime":"16:05 EDT","volume":119,"amount":3021.41,"timestamp":1745611513608},"delay":0,"floatShares":6292255,"shares":11018747,"eps":-7.832217,"marketStatus":"休市中","change":-0.08,"latestTime":"04-25 16:00:00 EDT","open":25.06,"high":26.79,"low":24.29,"amount":1656488.118,"amplitude":0.098155,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.832217,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":25.47,"preHourTrading":{"tag":"盘前","latestPrice":25.89,"preClose":25.47,"latestTime":"04:05 EDT","volume":2,"amount":49.239998,"timestamp":1745568323112},"postHourTrading":{"tag":"盘后","latestPrice":25.39,"preClose":25.39,"latestTime":"16:05 EDT","volume":119,"amount":3021.41,"timestamp":1745611513608},"volumeRatio":0.5812802236780464,"impliedVol":0.261,"impliedVolPercentile":0.3934},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":6292255,"roa":"-18.39%","roe":"-59.37%","lyrEps":-7.832217,"volumeRatio":0.5812802236780464,"shares":11018747,"dividePrice":0,"high":26.79,"amplitude":0.098155,"preClose":25.47,"low":24.29,"week52Low":6.2,"pbRate":"4.47","week52High":29.27,"institutionHeld":0,"latestPrice":25.39,"eps":-7.832217,"divideRate":0,"volume":65991,"delay":0,"ttmEps":-7.832217,"open":25.06,"prevYearClose":12,"prevWeekClose":24.36,"prevMonthClose":27.99,"prevQuarterClose":27.99,"fiveDayClose":24.36,"twentyDayClose":27.76,"sixtyDayClose":13.31},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":534271315,"employeeNum":14,"address":"125 Strafford Avenue,Suite 360,Wayne,Pennsylvania,United States","zipCode":"19087","officePhone":"484 253 1461"},"stockCompanyDetail":{"websiteUrl":"http://www.pieris.com","stockEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0909},{"period":"3month","weight":1.0328},{"period":"6month","weight":0.499},{"period":"1year","weight":1.1888},{"period":"ytd","weight":1.1158}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Palvella Therapeutics, Inc.在内华达的法律下成立于2013年5月24日。该公司是一家生物技术公司，历史上发现并开发了基于Anticalin蛋白的药物，以独特和变革性的方式靶向已验证的疾病途径。2024年3月27日，公司实施了措施，以最大限度地提高其从其合作候选药物临床管道收集潜在里程碑的能力，并保持其考虑其他战略选择的能力。该公司的临床管线包括与合作者合作的免疫肿瘤学或IO双特异性药物，包括靶向PD-L1和4-1BB的S095012（也称PRS-344）、靶向CD228和4-1BB的SGN-BB228（也称PRS-346）以及靶向GPC3和4-1BB的BOS-342（也称PRS-342）。Anticalin蛋白是公司专有的，是一类新型疗法，已在临床上通过与领先制药公司的合作关系得到验证。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.102904},{"month":2,"riseRate":0.5,"avgChangeRate":0.02179},{"month":3,"riseRate":0.5,"avgChangeRate":0.012293},{"month":4,"riseRate":0.2,"avgChangeRate":-0.078151},{"month":5,"riseRate":0.555556,"avgChangeRate":0.187589},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.091514},{"month":7,"riseRate":0.7,"avgChangeRate":0.124373},{"month":8,"riseRate":0.6,"avgChangeRate":0.081761},{"month":9,"riseRate":0.3,"avgChangeRate":-0.115283},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082714},{"month":11,"riseRate":0.5,"avgChangeRate":0.04477},{"month":12,"riseRate":0.3,"avgChangeRate":-0.058257}],"exchange":"NASDAQ","name":"Palvella Therapeutics","nameEN":"Palvella Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":{"directors":[{"name":"James Geraghty","position":"Director and Chairman"},{"name":"Stephen S. Yoder","position":"Director,Chief Executive Officer and President"},{"name":"Ann Barbier","position":"Director"},{"name":"Christopher Kiritsy","position":"Director"},{"name":"Jean Pierre Bizzari","position":"Director"},{"name":"Michael Richman","position":"Director"},{"name":"Steven Prelack","position":"Director"}],"executives":[{"name":"Stephen S. Yoder","position":"Director,Chief Executive Officer and President"},{"name":"Allan Reine","position":"Senior Vice President, Chief Financial Officer and Treasurer"},{"name":"Louis A. Matis","position":"Senior Vice President and Chief Development Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"PVLA","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":4},{"market":"US","date":"2024-11-13","symbol":"PVLA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.19},{"market":"US","date":"2024-08-14","symbol":"PVLA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-2.76},{"market":"US","date":"2024-05-15","symbol":"PVLA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-3.95},{"market":"US","date":"2024-04-23","symbol":"PVLA","defaultRemindTime":1713879000000,"type":"split","dateTimestamp":1713844800000,"forFactor":80,"toFactor":1,"ratio":80}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.8889,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8889,"analysts":9,"updateTime":1744257600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2025-04-25","current":-16.097711,"percent":0.037975,"low":-17.359106,"twenty":-12.583644,"median":23.043756,"eighty":39.236406,"high":46.119317,"avg":20.495462,"sd":20.299797,"marketCap":280647486},"quantilePoints":[{"date":"2025-01-03","current":19.083855,"twenty":19.083855,"median":19.083855,"eighty":19.083855,"marketCap":134655684},{"date":"2025-01-10","current":22.662078,"twenty":19.083855,"median":20.077806,"eighty":23.120091,"marketCap":159903624},{"date":"2025-01-17","current":21.024047,"twenty":19.083855,"median":21.024047,"eighty":22.483962,"marketCap":148345678},{"date":"2025-01-24","current":20.658273,"twenty":19.395558,"median":20.960435,"eighty":22.003685,"marketCap":145764777},{"date":"2025-01-31","current":21.469337,"twenty":19.914003,"median":20.93658,"eighty":21.408905,"marketCap":151487644},{"date":"2025-02-07","current":23.854819,"twenty":20.19708,"median":20.960435,"eighty":22.191343,"marketCap":168319605},{"date":"2025-02-14","current":31.806426,"twenty":20.537409,"median":21.047902,"eighty":23.471552,"marketCap":224426140},{"date":"2025-02-21","current":30.216104,"twenty":20.626467,"median":21.159225,"eighty":24.999851,"marketCap":213204833},{"date":"2025-02-28","current":29.977556,"twenty":20.64237,"median":22.089563,"eighty":29.977556,"marketCap":211521636},{"date":"2025-03-07","current":38.072292,"twenty":20.658273,"median":23.043756,"eighty":30.804523,"marketCap":268638089},{"date":"2025-03-14","current":43.224933,"twenty":20.674177,"median":23.473142,"eighty":31.806426,"marketCap":304995124},{"date":"2025-03-21","current":43.622513,"twenty":20.674177,"median":24.864674,"eighty":35.527777,"marketCap":307800451},{"date":"2025-03-28","current":44.147319,"twenty":20.912725,"median":26.844623,"eighty":43.224933,"marketCap":311503482},{"date":"2025-04-04","current":-15.431096,"twenty":20.674177,"median":26.264156,"eighty":43.368061,"marketCap":269025725},{"date":"2025-04-11","current":-12.558363,"twenty":20.515145,"median":24.729496,"eighty":43.224933,"marketCap":218942502},{"date":"2025-04-17","current":-15.421442,"twenty":19.083855,"median":23.473142,"eighty":40.654974,"marketCap":268857426},{"date":"2025-04-25","current":-16.097711,"twenty":-12.583644,"median":23.043756,"eighty":39.236406,"marketCap":280647486}],"updateTime":1745805419688}}}